Auro Laboratories Ltd.
| BSE: 530233 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE292C01011 |
| BSE 13:39 | 20 Apr | 84.90 |
2.00 (2.41%) |
OPEN
84.50 |
HIGH
85.00 |
LOW
81.30 |
| NSE 05:30 | 01 Jan | Auro Laboratories Ltd |
| OPEN | 84.50 |
| PREVIOUS CLOSE | 82.90 |
| VOLUME | 12158 |
| 52-Week high | 128.40 |
| 52-Week low | 35.15 |
| P/E | 8.62 |
| Mkt Cap.(Rs cr) | 53 |
| Buy Price | 84.90 |
| Buy Qty | 14.00 |
| Sell Price | 84.95 |
| Sell Qty | 34.00 |
Auro Laboratories Ltd. (AUROLABS) - Company Information
Auro Laboratories Ltd
Auro Laboratories is a manufacturer of Active Pharmaceutical Ingredients (API's) Intermediates and Generic Formulations. Auro Laboratories was founded and incorporated in 1992 at Mumbai with a manufacturing facility located at Tarapur 120 Km from Mumbai. Since inception the company has focused on providing quality pharmaceuticals while maintaining high manufacturing standards.The company's primary...> More
| COMPANY INFORMATION | |||||||
| Chairman & Managing Director : | Sharat Deorah | ||||||
| Whole-time Director : | Siddhartha Deorah | ||||||
| Independent Director : | Goverdhandas Aggarwal | ||||||
| Independent Director : | Kailash Chandra Bubna | ||||||
| Director : | Kavita Vijayakant Sharma | ||||||
| Company Secretary : | Shanu Nag | ||||||
| Independent Director : | Kavita Vijayakant Sharma | ||||||
| AUDITOR : | Khurdia Jain & Co | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| K-56 MIDC Indl Area, Tarapur Boisar,Thane,Maharashtra-401506 | |||||||
| Ph : 91-22-66635456 | |||||||
| WEBSITE : http://www.aurolabs.com | |||||||
| E-mail : auro@aurolabs.com | |||||||
Quick Links for Auro Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
